Prevention of Pressure Ulcers in Patients at High Risk of Developping Pressure Ulcers Using the Low-pressure Motorized Air Support Mattress With XTECH®25 Control Unit

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSYSTAM

About this trial

The aim of the study is to determine the clinical value of using a a low air pressure motorised therapeutic mattress in the prevention of pressure injury (PI) in patients at medium to high risk.

This study is noncomparative, observational study.

Patients older than 18 years of age, with a high risk of PI, without PI, lying more than 20 hours a day on a XTECH®25 mattress will be included. The study will be conducted in nursing homes, and in long-stay geriatrics department.

Patients are followed up for 35 days. The use of the XTECH®25 mattress is associated with the usual PI prevention measures. The primary outcome is the percentage of patients who developed between day 0 and day 35 at least one PI of at least stage 2 on the sacrum, spine, or heel. Secondary endpoints are patient assessments of comfort, caregiver satisfaction, mattress noise level, and mattress safety.

Eligibility criteria

Qualifiers

Patient over 18 years old

Patient with high risk of developing pressure ulcers (clinical judgment and a score <= 12 on the Braden scale (6 (maximum risk) to 23 (no risk))

Patient without pressure injury on the day of inclusion

Patient up lying more than 20 hours a day on XTECH®25 mattress

Disqualifiers

Patient at end of life (estimated life expectancy less than 6 months)

Patient discharge from the establishment expected within two months

Significant unintentional weight loss: A weight loss of ≥ 5% within 1 month or ≥ 10% within 6 months

Low Body Mass Index (BMI): BMI < 18.5 kg/m² for individuals under 70 years old, BMI < 21 kg/m² for individuals aged 70 years and older

Trial design

Treatments tested in this trial

  • Use of a powered low air pressure motorised therapeutic mattress that combines the motorised and static technologies

Treatment groups

80 Participants
are divided into 1 treatment group

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Multiples locationsRecruiting Multiple LocationsFranceFrance

Sponsors and collaborators

SYSTAM

Lead sponsor

Clin-Experts

Collaborator